Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.

Gisbert JP, Gomollón F.

Am J Gastroenterol. 2008 Jul;103(7):1783-800. doi: 10.1111/j.1572-0241.2008.01848.x. Epub 2008 Jun 28. Review.

PMID:
18557712
[PubMed - indexed for MEDLINE]
2.

[The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].

Kim JH, Cheon JH, Kim WH.

Korean J Gastroenterol. 2008 May;51(5):291-7. Korean.

PMID:
18516013
[PubMed - indexed for MEDLINE]
Free Article
3.

Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.

Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA.

Am J Gastroenterol. 2003 May;98(5):1058-63.

PMID:
12809828
[PubMed - indexed for MEDLINE]
4.

The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.

Gao X, Zhang FB, Ding L, Liu H, Wang XD, Chen BL, Bi HC, Xiao YL, Zhao LZ, Chen MH, Huang M, Hu PJ.

Eur J Gastroenterol Hepatol. 2012 Aug;24(8):958-64. doi: 10.1097/MEG.0b013e3283545ae3.

PMID:
22664938
[PubMed - indexed for MEDLINE]
5.

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.

Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, Menchén L, Martín-Arranz MD, Opio V, Carneros JA, Van-Domselaar M, Mendoza JL, Luna M, López P, Calvo M, Algaba A.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):623-8. doi: 10.1111/j.1365-2036.2008.03746.x. Epub 2008 May 30.

PMID:
18513380
[PubMed - indexed for MEDLINE]
6.

[Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].

Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.

Med Clin (Barc). 2003 Jun 7;121(1):1-5. Spanish.

PMID:
12812701
[PubMed - indexed for MEDLINE]
7.

Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger.

Grossman AB, Noble AJ, Mamula P, Baldassano RN.

Inflamm Bowel Dis. 2008 Jun;14(6):750-5. doi: 10.1002/ibd.20387.

PMID:
18266236
[PubMed - indexed for MEDLINE]
8.

Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.

Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.

Hepatogastroenterology. 2006 May-Jun;53(69):399-404.

PMID:
16795981
[PubMed - indexed for MEDLINE]
9.

Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.

Shaye OA, Yadegari M, Abreu MT, Poordad F, Simon K, Martin P, Papadakis KA, Ippoliti A, Vasiliauskas E, Tran TT.

Am J Gastroenterol. 2007 Nov;102(11):2488-94. Epub 2007 Aug 31.

PMID:
17764490
[PubMed - indexed for MEDLINE]
10.

Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.

Gisbert JP, González-Lama Y, Maté J.

Am J Gastroenterol. 2007 Jul;102(7):1518-27. Epub 2007 Mar 27. Review.

PMID:
17391318
[PubMed - indexed for MEDLINE]
11.

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.

Ansari A, Elliott T, Baburajan B, Mayhead P, O'Donohue J, Chocair P, Sanderson J, Duley J.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):734-41.

PMID:
19145729
[PubMed - indexed for MEDLINE]
12.

Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.

Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1025-9. Epub 2006 Jun 9.

PMID:
16765651
[PubMed - indexed for MEDLINE]
13.

Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.

Gisbert JP, Luna M, González-Lama Y, Pousa ID, Velasco M, Moreno-Otero R, Maté J.

Inflamm Bowel Dis. 2007 Sep;13(9):1106-14.

PMID:
17455203
[PubMed - indexed for MEDLINE]
14.

Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.

Banerjee S, Bishop WP.

J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):324-30.

PMID:
16954954
[PubMed - indexed for MEDLINE]
15.

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE.

Gut. 1993 Aug;34(8):1081-5.

PMID:
8174958
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B.

Am J Gastroenterol. 2008 Dec;103(12):3115-22. doi: 10.1111/j.1572-0241.2008.01743.x. Erratum in: Am J Gastroenterol. 2009 Apr;104(4):1072. Biroulet, Laurent P [corrected to Peyrin-Biroulet, Laurent]. Retraction in: Am J Gastroenterol. 2009 Mar;104(3):801.

PMID:
19086961
[PubMed - indexed for MEDLINE]
17.

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.

Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA.

Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):563-7.

PMID:
15317038
[PubMed - indexed for MEDLINE]
18.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
[PubMed - indexed for MEDLINE]
19.

Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.

López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.

Gastroenterol Hepatol. 2011 Jun-Jul;34(6):385-92. doi: 10.1016/j.gastrohep.2011.03.023. Epub 2011 May 25.

PMID:
21616565
[PubMed - indexed for MEDLINE]
20.

Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.

Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL.

J Pediatr Gastroenterol Nutr. 2004 May;38(5):509-12.

PMID:
15097439
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk